+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Direct-to-Consumer Genetic Testing Market - Global Forecast to 2030- Product Image
Direct-to-Consumer Genetic Testing Market - Global Forecast to 2030- Product Image
Sale

Direct-to-Consumer Genetic Testing Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968843
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Direct-to-Consumer Genetic Testing Market grew from USD 2.36 billion in 2024 to USD 2.79 billion in 2025. It is expected to continue growing at a CAGR of 17.26%, reaching USD 6.16 billion by 2030.

The direct-to-consumer genetic testing market has undergone a remarkable evolution, propelled by advancements in genomic science, reductions in sequencing costs and growing consumer empowerment. Once confined to research laboratories and specialized clinics, genetic analysis is now readily accessible through at-home kits that illuminate ancestry, health risks, pharmacogenomic profiles and personal traits. This introduction outlines the market’s catalysts and underscores the strategic significance of understanding consumer motivations, technological drivers and regulatory dynamics. By laying the groundwork, we aim to equip decision-makers with a clear perspective on how personalized genomics is reshaping preventive healthcare, wellness services and the broader healthcare ecosystem.

Transformative Shifts Reshaping the DTC Genetic Testing Landscape

The landscape of direct-to-consumer genetic testing is being reshaped by several concurrent forces. Technological breakthroughs in next-generation sequencing have dramatically increased throughput while driving down costs, unlocking more comprehensive health-risk assessments. At the same time, heightened consumer engagement with digital health platforms and wearable devices is fostering demand for seamless integration of genomic insights into everyday wellness and disease prevention routines. Regulatory bodies around the world are also adopting more nuanced frameworks to balance innovation with consumer protection, encouraging responsible growth. Together, these shifts are transforming the market from a novelty-driven segment into a cornerstone of personalized medicine.

Cumulative Impact of United States Tariffs in 2025 on the DTC Genetic Testing Sector

The implementation of new U.S. tariffs in 2025 has introduced added complexity into the supply chains that underpin direct-to-consumer genetic testing. Import duties on specialized reagents, microarrays and sequencing equipment have increased cost structures for providers, prompting many to reassess sourcing strategies and negotiate volume discounts with domestic manufacturers. Some companies have responded by establishing localized production facilities or diversifying partnerships with reagent suppliers in tariff-exempt regions. While short-term pricing adjustments have been necessary, these shifts are also encouraging greater supply-chain resilience and fostering innovation in assay design and reagent efficiency.

Key Segmentation Insights Driving Market Personalization

A nuanced understanding of market segments is essential for tailoring offerings and maximizing engagement. When viewed by product type, ancestry testing retains its role as the gateway service, yet carrier testing, health risk assessment and pharmacogenomics are rapidly gaining traction among consumers seeking actionable medical insights. Analysis by technology reveals that next-generation sequencing is eclipsing microarray platforms, supported by the growing demand for comprehensive genome-wide association studies, while polymerase chain reaction and single-cell genomics carve out specialized niches. Among sample types, saliva and buccal swab kits continue to dominate thanks to their ease of collection, though blood-based assays and emerging nanopore approaches underscore the push for higher fidelity data. From an end-user perspective, individuals account for the majority of kit purchases, but healthcare providers and research institutions are increasingly leveraging DTC platforms to augment patient care and drive clinical studies. Age-group analysis highlights distinct preferences: Baby Boomers emphasize disease-prevention screenings, Gen X and Millennials balance health risk reports with lifestyle guidance, while Gen Z prioritizes digital engagement through mobile apps and wearable integration. Purpose-driven segmentation underscores the rise of lifestyle and wellness tests alongside core health-screening services, with condition-specific offerings for diabetes predisposition, early-onset Alzheimer’s and heart disease risk prediction expanding rapidly. User-experience considerations such as clarity of results, ease of test collection, post-test counseling availability and seamless mobile-application usability are now critical differentiators. Consumer motivations range from curiosity and family-history investigation to medical insight and personal-health management, each demanding tailored communication strategies. Brand engagement revolves around community building with interactive content and online forums, trust and reliability, social media presence and customer-support satisfaction. Finally, payment models are diversifying from one-time purchases to subscription plans and insurance-coverage options, while marketing channels are broadening to include event sponsorships, influencer partnerships and targeted online ad campaigns.

Regional Dynamics Shaping Growth Across Key Geographies

Regional dynamics reveal differentiated growth trajectories. In the Americas, early adoption, high health-tech awareness and established direct-to-consumer regulations have fostered a mature market with robust uptake across ancestry, health-risk and pharmacogenomic tests. The Europe, Middle East & Africa region is characterized by diverse regulatory landscapes and increasing demand for data privacy and local compliance, driving providers to emphasize security and localized customer service. Asia-Pacific presents the most significant growth potential, fueled by young, tech-savvy populations, expanding healthcare infrastructure and government initiatives supporting genomic research. Providers targeting this region are capitalizing on mobile integration, tailored pricing strategies and partnerships with local laboratories to accelerate market penetration.

Competitive Landscape: Leading Players and Strategic Positioning

Competition in the direct-to-consumer genetic testing arena is intensifying, with leading players differentiating through technology, partnerships and service portfolios. Ancestry.com LLC continues to leverage its vast genealogical database and global marketing reach to maintain leadership in ancestry services. Dante Labs Inc. has distinguished itself through whole-genome sequencing offerings and subscription-based access to raw data. EasyDNA and FamilyTreeDNA by Gene, Ltd. focus on niche testing services, catering to forensic and specialized genealogy needs. Genesis Healthcare Co. and Shuwen Biotech Co. Ltd. are capitalizing on regional expertise in Asia, offering cost-effective panels and local language support. Helix OpCo, LLC has forged partnerships with clinical and wellness brands, integrating genomic insights into lifestyle programs. Karmagenes SA pioneers personalized nutritional genomics, while Living DNA Ltd. emphasizes granular regional ancestry analysis. Mapmygenome has excelled in the Indian market by combining health-risk and lifestyle reports. Merck KGaA provides critical reagents and microarray platforms to academic and commercial labs, supporting assay development. MyHeritage Ltd. merges genealogical passion with health screening. Positive Biosciences, Ltd. and Vitagene, Inc. innovate in RNA-based assays and personalized wellness blueprints respectively. Xcode Life offers a digital-first experience with deep analytics and API integrations for third-party developers.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize investing in next-generation sequencing infrastructure to support comprehensive health and trait panels while reducing per-sample costs. Diversifying supply chains by forging alliances with domestic and tariff-exempt reagent suppliers will mitigate geopolitical risk. Developing subscription and hybrid payment models can increase lifetime customer value and encourage repeat engagement. Enhancing digital channels-particularly mobile-app interfaces and wearable integration-will resonate with Gen Z and emerging Tech-Native segments. Formalizing partnerships with healthcare providers and research institutions will expand clinical credibility and drive B2B revenue streams. Maintaining rigorous compliance with evolving data-privacy and regulatory standards will preserve consumer trust. Finally, strengthening community engagement through interactive content, online forums and robust post-test counseling services will differentiate brands in an increasingly crowded landscape.

Conclusion: Navigating the Future of DTC Genetic Testing

The direct-to-consumer genetic testing market stands at a pivotal juncture, with converging forces of technological innovation, consumer empowerment and regulatory evolution driving rapid transformation. Companies that master the art of personalized segmentation, optimize supply chains in light of new tariffs and refine digital-first experiences will unlock significant competitive advantage. By embracing strategic partnerships, investing in advanced sequencing and aligning with regional market dynamics, industry players can navigate complexity and deliver meaningful genomic insights that resonate with a broad spectrum of end users.

Market Segmentation & Coverage

This research report categorizes the Direct-to-Consumer Genetic Testing Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Ancestry Testing
  • Carrier Testing
  • Health Risk Assessment
  • Personalized Medicine
  • Pharmacogenomics
  • Wellness & Trait Tests
  • Genome-Wide Association Studies (GWAS)
  • Microarray
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Single Cell Genomics
  • Blood
  • Buccal Swab
  • Nanopore
  • Saliva
  • Healthcare Providers
  • Individuals
  • Research Institutions
  • Baby Boomers
  • Emerging Trends in Age-Based Preferences
    • Digital Engagement for Gen Z
    • Health Consciousness in Millennials
  • Gen X
  • Gen Z
  • Millennials
  • Silent Generation
  • Condition Screening for Disease Prevention
    • Diabetes Predisposition
    • Early Onset Alzheimer's
    • Heart Disease Risk Prediction
  • Forensic & Paternity Testing
  • Genomic Research
  • Health Screening
  • Lifestyle & Wellness
  • Clarity of Results
  • Ease of Test Collection
  • Integration with Wearable Technology
  • Mobile Application Usability
  • Post-Test Counseling Availability
  • Curiosity
  • Family History Investigation
  • Medical Insight
  • Personal Health Management
  • Community Building and Engagement
    • Interactive Content
    • Online Forums
  • Customer Support Satisfaction
  • Social Media Presence
  • Trust & Reliability
  • Financial Assistance Programs
  • Insurance Coverage
  • One-Time Purchase
  • Subscription Model
  • Event Sponsorships
  • Influencer Partnerships
  • Online Ad Campaigns
  • Television & Radio Ads

This research report categorizes the Direct-to-Consumer Genetic Testing Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Direct-to-Consumer Genetic Testing Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Ancestry.com LLC
  • Dante Labs Inc.
  • EasyDNA
  • FamilyTreeDNA by Gene, Ltd.
  • Genesis Healthcare Co.
  • Helix OpCo, LLC
  • Karmagenes SA
  • Living DNA Ltd.
  • Mapmygenome
  • Merck KGaA
  • MyHeritage Ltd.
  • Positive Biosciences, Ltd.
  • Shuwen Biotech Co. Ltd.
  • Vitagene, Inc.
  • Xcode Life

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Direct-to-Consumer Genetic Testing Market, by Product Type
8.1. Introduction
8.2. Ancestry Testing
8.3. Carrier Testing
8.4. Health Risk Assessment
8.5. Personalized Medicine
8.6. Pharmacogenomics
8.7. Wellness & Trait Tests
9. Direct-to-Consumer Genetic Testing Market, by Technology
9.1. Introduction
9.2. Genome-Wide Association Studies (GWAS)
9.3. Microarray
9.4. Next-Generation Sequencing (NGS)
9.5. Polymerase Chain Reaction (PCR)
9.6. Single Cell Genomics
10. Direct-to-Consumer Genetic Testing Market, by Sample Type
10.1. Introduction
10.2. Blood
10.3. Buccal Swab
10.4. Nanopore
10.5. Saliva
11. Direct-to-Consumer Genetic Testing Market, by End User
11.1. Introduction
11.2. Healthcare Providers
11.3. Individuals
11.4. Research Institutions
12. Direct-to-Consumer Genetic Testing Market, by Age Group
12.1. Introduction
12.2. Baby Boomers
12.3. Emerging Trends in Age-Based Preferences
12.3.1. Digital Engagement for Gen Z
12.3.2. Health Consciousness in Millennials
12.4. Gen X
12.5. Gen Z
12.6. Millennials
12.7. Silent Generation
13. Direct-to-Consumer Genetic Testing Market, by Purpose
13.1. Introduction
13.2. Condition Screening for Disease Prevention
13.2.1. Diabetes Predisposition
13.2.2. Early Onset Alzheimer's
13.2.3. Heart Disease Risk Prediction
13.3. Forensic & Paternity Testing
13.4. Genomic Research
13.5. Health Screening
13.6. Lifestyle & Wellness
14. Direct-to-Consumer Genetic Testing Market, by User Experience
14.1. Introduction
14.2. Clarity of Results
14.3. Ease of Test Collection
14.4. Integration with Wearable Technology
14.5. Mobile Application Usability
14.6. Post-Test Counseling Availability
15. Direct-to-Consumer Genetic Testing Market, by Consumer Motivation
15.1. Introduction
15.2. Curiosity
15.3. Family History Investigation
15.4. Medical Insight
15.5. Personal Health Management
16. Direct-to-Consumer Genetic Testing Market, by Brand Engagement
16.1. Introduction
16.2. Community Building and Engagement
16.2.1. Interactive Content
16.2.2. Online Forums
16.3. Customer Support Satisfaction
16.4. Social Media Presence
16.5. Trust & Reliability
17. Direct-to-Consumer Genetic Testing Market, by Payment Method
17.1. Introduction
17.2. Financial Assistance Programs
17.3. Insurance Coverage
17.4. One-Time Purchase
17.5. Subscription Model
18. Direct-to-Consumer Genetic Testing Market, by Marketing Channel
18.1. Introduction
18.2. Event Sponsorships
18.3. Influencer Partnerships
18.4. Online Ad Campaigns
18.5. Television & Radio Ads
19. Americas Direct-to-Consumer Genetic Testing Market
19.1. Introduction
19.2. Argentina
19.3. Brazil
19.4. Canada
19.5. Mexico
19.6. United States
20. Asia-Pacific Direct-to-Consumer Genetic Testing Market
20.1. Introduction
20.2. Australia
20.3. China
20.4. India
20.5. Indonesia
20.6. Japan
20.7. Malaysia
20.8. Philippines
20.9. Singapore
20.10. South Korea
20.11. Taiwan
20.12. Thailand
20.13. Vietnam
21. Europe, Middle East & Africa Direct-to-Consumer Genetic Testing Market
21.1. Introduction
21.2. Denmark
21.3. Egypt
21.4. Finland
21.5. France
21.6. Germany
21.7. Israel
21.8. Italy
21.9. Netherlands
21.10. Nigeria
21.11. Norway
21.12. Poland
21.13. Qatar
21.14. Russia
21.15. Saudi Arabia
21.16. South Africa
21.17. Spain
21.18. Sweden
21.19. Switzerland
21.20. Turkey
21.21. United Arab Emirates
21.22. United Kingdom
22. Competitive Landscape
22.1. Market Share Analysis, 2024
22.2. FPNV Positioning Matrix, 2024
22.3. Competitive Analysis
22.3.1. Ancestry.com LLC
22.3.2. Dante Labs Inc.
22.3.3. EasyDNA
22.3.4. FamilyTreeDNA by Gene, Ltd.
22.3.5. Genesis Healthcare Co.
22.3.6. Helix OpCo, LLC
22.3.7. Karmagenes SA
22.3.8. Living DNA Ltd.
22.3.9. Mapmygenome
22.3.10. Merck KGaA
22.3.11. MyHeritage Ltd.
22.3.12. Positive Biosciences, Ltd.
22.3.13. Shuwen Biotech Co. Ltd.
22.3.14. Vitagene, Inc.
22.3.15. Xcode Life
23. ResearchAI
24. ResearchStatistics
25. ResearchContacts
26. ResearchArticles
27. Appendix
List of Figures
FIGURE 1. DIRECT-TO-CONSUMER GENETIC TESTING MARKET MULTI-CURRENCY
FIGURE 2. DIRECT-TO-CONSUMER GENETIC TESTING MARKET MULTI-LANGUAGE
FIGURE 3. DIRECT-TO-CONSUMER GENETIC TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PURPOSE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PURPOSE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY USER EXPERIENCE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY USER EXPERIENCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONSUMER MOTIVATION, 2024 VS 2030 (%)
FIGURE 22. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONSUMER MOTIVATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BRAND ENGAGEMENT, 2024 VS 2030 (%)
FIGURE 24. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BRAND ENGAGEMENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PAYMENT METHOD, 2024 VS 2030 (%)
FIGURE 26. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PAYMENT METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MARKETING CHANNEL, 2024 VS 2030 (%)
FIGURE 28. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MARKETING CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 32. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 34. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 35. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 36. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 37. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 38. DIRECT-TO-CONSUMER GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CARRIER TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS & TRAIT TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GENOME-WIDE ASSOCIATION STUDIES (GWAS), BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SINGLE CELL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUCCAL SWAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NANOPORE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY INDIVIDUALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BABY BOOMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EMERGING TRENDS IN AGE-BASED PREFERENCES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY DIGITAL ENGAGEMENT FOR GEN Z, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH CONSCIOUSNESS IN MILLENNIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EMERGING TRENDS IN AGE-BASED PREFERENCES, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GEN X, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GEN Z, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MILLENNIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SILENT GENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONDITION SCREENING FOR DISEASE PREVENTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY DIABETES PREDISPOSITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EARLY ONSET ALZHEIMER'S, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEART DISEASE RISK PREDICTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONDITION SCREENING FOR DISEASE PREVENTION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FORENSIC & PATERNITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GENOMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CLARITY OF RESULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EASE OF TEST COLLECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY INTEGRATION WITH WEARABLE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MOBILE APPLICATION USABILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POST-TEST COUNSELING AVAILABILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONSUMER MOTIVATION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CURIOSITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FAMILY HISTORY INVESTIGATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MEDICAL INSIGHT, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PERSONAL HEALTH MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BRAND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COMMUNITY BUILDING AND ENGAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY INTERACTIVE CONTENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONLINE FORUMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COMMUNITY BUILDING AND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CUSTOMER SUPPORT SATISFACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SOCIAL MEDIA PRESENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRUST & RELIABILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PAYMENT METHOD, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FINANCIAL ASSISTANCE PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY INSURANCE COVERAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONE-TIME PURCHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SUBSCRIPTION MODEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EVENT SPONSORSHIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY INFLUENCER PARTNERSHIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONLINE AD CAMPAIGNS, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TELEVISION & RADIO ADS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EMERGING TRENDS IN AGE-BASED PREFERENCES, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONDITION SCREENING FOR DISEASE PREVENTION, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONSUMER MOTIVATION, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BRAND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COMMUNITY BUILDING AND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PAYMENT METHOD, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EMERGING TRENDS IN AGE-BASED PREFERENCES, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONDITION SCREENING FOR DISEASE PREVENTION, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONSUMER MOTIVATION, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BRAND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COMMUNITY BUILDING AND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PAYMENT METHOD, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EMERGING TRENDS IN AGE-BASED PREFERENCES, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONDITION SCREENING FOR DISEASE PREVENTION, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONSUMER MOTIVATION, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BRAND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COMMUNITY BUILDING AND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PAYMENT METHOD, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 121. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 123. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 125. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EMERGING TRENDS IN AGE-BASED PREFERENCES, 2018-2030 (USD MILLION)
TABLE 126. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
TABLE 127. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONDITION SCREENING FOR DISEASE PREVENTION, 2018-2030 (USD MILLION)
TABLE 128. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 129. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONSUMER MOTIVATION, 2018-2030 (USD MILLION)
TABLE 130. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BRAND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 131. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COMMUNITY BUILDING AND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 132. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PAYMENT METHOD, 2018-2030 (USD MILLION)
TABLE 133. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 137. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 139. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EMERGING TRENDS IN AGE-BASED PREFERENCES, 2018-2030 (USD MILLION)
TABLE 140. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
TABLE 141. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONDITION SCREENING FOR DISEASE PREVENTION, 2018-2030 (USD MILLION)
TABLE 142. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 143. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONSUMER MOTIVATION, 2018-2030 (USD MILLION)
TABLE 144. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BRAND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 145. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COMMUNITY BUILDING AND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 146. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PAYMENT METHOD, 2018-2030 (USD MILLION)
TABLE 147. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EMERGING TRENDS IN AGE-BASED PREFERENCES, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONDITION SCREENING FOR DISEASE PREVENTION, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONSUMER MOTIVATION, 2018-2030 (USD MILLION)
TABLE 158. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BRAND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 159. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COMMUNITY BUILDING AND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PAYMENT METHOD, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EMERGING TRENDS IN AGE-BASED PREFERENCES, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONDITION SCREENING FOR DISEASE PREVENTION, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONSUMER MOTIVATION, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BRAND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COMMUNITY BUILDING AND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PAYMENT METHOD, 2018-2030 (USD MILLION)
TABLE 176. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 178. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 181. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 183. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EMERGING TRENDS IN AGE-BASED PREFERENCES, 2018-2030 (USD MILLION)
TABLE 184. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
TABLE 185. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONDITION SCREENING FOR DISEASE PREVENTION, 2018-2030 (USD MILLION)
TABLE 186. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 187. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONSUMER MOTIVATION, 2018-2030 (USD MILLION)
TABLE 188. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BRAND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COMMUNITY BUILDING AND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PAYMENT METHOD, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 195. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 197. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EMERGING TRENDS IN AGE-BASED PREFERENCES, 2018-2030 (USD MILLION)
TABLE 198. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
TABLE 199. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONDITION SCREENING FOR DISEASE PREVENTION, 2018-2030 (USD MILLION)
TABLE 200. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 201. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONSUMER MOTIVATION, 2018-2030 (USD MILLION)
TABLE 202. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BRAND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 203. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COMMUNITY BUILDING AND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 204. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PAYMENT METHOD, 2018-2030 (USD MILLION)
TABLE 205. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 209. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 211. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EMERGING TRENDS IN AGE-BASED PREFERENCES, 2018-2030 (USD MILLION)
TABLE 212. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
TABLE 213. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONDITION SCREENING FOR DISEASE PREVENTION, 2018-2030 (USD MILLION)
TABLE 214. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 215. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONSUMER MOTIVATION, 2018-2030 (USD MILLION)
TABLE 216. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BRAND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 217. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COMMUNITY BUILDING AND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 218. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PAYMENT METHOD, 2018-2030 (USD MILLION)
TABLE 219. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 222. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 223. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 225. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EMERGING TRENDS IN AGE-BASED PREFERENCES, 2018-2030 (USD MILLION)
TABLE 226. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
TABLE 227. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONDITION SCREENING FOR DISEASE PREVENTION, 2018-2030 (USD MILLION)
TABLE 228. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 229. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONSUMER MOTIVATION, 2018-2030 (USD MILLION)
TABLE 230. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BRAND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 231. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COMMUNITY BUILDING AND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 232. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PAYMENT METHOD, 2018-2030 (USD MILLION)
TABLE 233. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 236. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 237. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 239. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EMERGING TRENDS IN AGE-BASED PREFERENCES, 2018-2030 (USD MILLION)
TABLE 240. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
TABLE 241. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONDITION SCREENING FOR DISEASE PREVENTION, 2018-2030 (USD MILLION)
TABLE 242. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 243. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONSUMER MOTIVATION, 2018-2030 (USD MILLION)
TABLE 244. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BRAND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 245. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COMMUNITY BUILDING AND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 246. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PAYMENT METHOD, 2018-2030 (USD MILLION)
TABLE 247. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 248. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 251. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 253. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EMERGING TRENDS IN AGE-BASED PREFERENCES, 2018-2030 (USD MILLION)
TABLE 254. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
TABLE 255. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONDITION SCREENING FOR DISEASE PREVENTION, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONSUMER MOTIVATION, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BRAND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COMMUNITY BUILDING AND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PAYMENT METHOD, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 264. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 265. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 267. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EMERGING TRENDS IN AGE-BASED PREFERENCES, 2018-2030 (USD MILLION)
TABLE 268. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
TABLE 269. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONDITION SCREENING FOR DISEASE PREVENTION, 2018-2030 (USD MILLION)
TABLE 270. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 271. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CONSUMER MOTIVATION, 2018-2030 (USD MILLION)
TABLE 272. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BRAND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 273. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COMMUNITY BUILDING AND ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 274. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PAYMENT METHOD, 2018-2030 (USD MILLION)
TABLE 275. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 278. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 279. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 281. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EMERGING TRENDS IN AGE-BASED PREFERENCES, 2018-2030 (USD MILLION)
TABLE 282. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PURPOSE,

Companies Mentioned

  • Ancestry.com LLC
  • Dante Labs Inc.
  • EasyDNA
  • FamilyTreeDNA by Gene, Ltd.
  • Genesis Healthcare Co.
  • Helix OpCo, LLC
  • Karmagenes SA
  • Living DNA Ltd.
  • Mapmygenome
  • Merck KGaA
  • MyHeritage Ltd.
  • Positive Biosciences, Ltd.
  • Shuwen Biotech Co. Ltd.
  • Vitagene, Inc.
  • Xcode Life

Methodology

Loading
LOADING...

Related Topics

Related Reports

Direct-To-Consumer (DTC) Genetic Testing - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Direct-To-Consumer (DTC) Genetic Testing - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Genetic Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 To 2032 - Product Image

Genetic Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 To 2032

  • Report
  • 171 Pages
  • Global
From
Predictive Genetic Testing and Consumer Genomics Market Size, Share & Trends Analysis Report by Test, Application, Setting (DTC, Professional), Region, and Segment Forecasts, 2025-2030 - Product Image

Predictive Genetic Testing and Consumer Genomics Market Size, Share & Trends Analysis Report by Test, Application, Setting (DTC, Professional), Region, and Segment Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Genetic Testing Market Size, Share & Trends Analysis Report By Technology (NGS, PCR-based Testing, Array Technology), By Application, By Product, By Channel (Online, Offline), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Genetic Testing Market Size, Share & Trends Analysis Report By Technology (NGS, PCR-based Testing, Array Technology), By Application, By Product, By Channel (Online, Offline), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Global Hereditary Genetic Testing Market: Focus on Product, Sample Type, Technology, Genetic Testing Type, Application Area, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033 - Product Image

Global Hereditary Genetic Testing Market: Focus on Product, Sample Type, Technology, Genetic Testing Type, Application Area, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033

  • Report
  • 113 Pages
  • Global
From

About the Direct to Consumer Genetic Testing Market

Direct to Consumer Genetic Testing (DTCGT) is a type of genetic testing that allows individuals to access their genetic information without the need for a doctor or other healthcare provider. DTCGT companies provide genetic testing services directly to consumers, typically through a simple saliva sample. The results of the test can provide insight into an individual's ancestry, health risks, and other genetic traits. The DTCGT market has grown rapidly in recent years, driven by advances in genomics technology and the increasing availability of affordable testing services. Consumers are increasingly turning to DTCGT to gain access to their genetic information and to learn more about their health and ancestry. Some of the leading companies in the DTCGT market include 23andMe, AncestryDNA, Helix, and MyHeritage. These companies offer a range of services, from ancestry testing to health risk assessments. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.